Otsuka Holdings Co., Ltd. OTSKF
Set alert
At close · Oct 30
- YTD
- +34.82%
- 1 year
- +27.54%
- Open
- 72.00
- Prev close
- 73.16
- Mkt cap
- 38.33B
- Vol
- 41
- Avg vol
- 13
- EPS
- 4.94
- P/E
- 14.81
More statistics
- Low
- 72.00
- High
- 72.00
- Earnings
- Nov 4, 2026
News
5 months ago seekingalpha.com
Aristotle International Equity ADR WM Q1 2026 Contributors And Detractors
For the first quarter of 2026, Aristotle Capital's International Equity ADR WM Composite posted a total return of -3.39% gross of fees. MonotaRO, the Japanese business-to-business e-commerce…
6 months ago seekingalpha.com
Otsuka Holdings Co., Ltd. (OTSKY) M&A Call Prepared Remarks Transcript
Otsuka Holdings Co., Ltd. (OTSKY) M&A Call Prepared Remarks Transcript
8 months ago seekingalpha.com
Otsuka Holdings Co., Ltd. (OTSKY) Q4 2025 Earnings Call Prepared Remarks Transcript
Otsuka Holdings Co., Ltd. (OTSKY) Q4 2025 Earnings Call Prepared Remarks Transcript
8 months ago benzinga.com
Neumora Therapeutics Stock Jumps, Analyst Sees Upside In Alzheimer's Treatment
William Blair upgrades Neumora after strong Alzheimer's agitation data, sees upside from NMRA-511 and obesity pipeline potential.
8 months ago defenseworld.net
Otsuka (OTCMKTS:OTSKF) Trading Up 3% – Should You Buy?
Otsuka Holdings Co., Ltd. (OTCMKTS:OTSKF - Get Free Report) shares shot up 3% during mid-day trading on Wednesday. The company traded as high as $61.42 and last traded at $61.42. 200 shares traded…
9 months ago benzinga.com
Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle
CMS selects 15 high-cost prescription drugs for Medicare drug price negotiation program, expanding to include Part B drugs.
11 months ago reuters.com
US FDA approves Otsuka's kidney disease drug
The U.S. Food and Drug Administration has approved Otsuka's injectable drug to treat patients with a potentially life-threatening kidney disease, the health regulator's website showed on Tuesday.
1 year ago seekingalpha.com
Otsuka Corporation (OSUKF) Q1 FY2025 Earnings Call Transcript
Otsuka Corporation (OTCPK:OSUKF) Q1 FY2025 Earnings Conference Call August 1, 2025 2:30 AM ET Company Participants Yuji Otsuka - CEO, President, Chairman & MM Division Chief Yuji Otsuka I am Otsuka…